Company Universal Ibogaine Inc. Toronto S.E.
Equities
IBO
CA69379R1082
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | -33.33% | -33.33% | +100.00% |
04-22 | Universal Ibogaine Inc. Elects Ken Cranwill as Board of Director | CI |
04-22 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding | CI |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Addiction Treatment Clinics and Ibogaine
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.81% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -3.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - | |
Dugan Selkirk
IRC | Investor Relations Contact | - | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
James Duncan
BRD | Director/Board Member | - | 23-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 233,512,849 | 231,177,720 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Universal Ibogaine, Inc.
815 8th Avenue South West Suite 600
T2P 3P2, Calgary
+855-426-4246
http://www.universalibogaine.comSector
1st Jan change | Capi. | |
---|---|---|
+13.70% | 80.61B | |
-29.20% | 70.18B | |
+9.86% | 29.12B | |
-11.43% | 16.97B | |
-0.61% | 16.96B | |
-0.31% | 15.26B | |
+4.74% | 12.41B | |
-30.88% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- IBO Stock
- IBO Stock
- Company Universal Ibogaine Inc.